Clinical Trial Update: A Long-term Administration Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Schizophrenia [Phase 3]

View source ↗

Summary

This is a Phase 3 long-term, once-weekly brexpiprazole trial in schizophrenia that is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• brexpiprazole (brexpiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Schizophrenia | Phase 3 | Status: ACTIVE_NOT_RECRUITING